https://doi.org/10.1186/s12890-023-02376-w
A
Aditi Shah
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
112
Papers
921
Citations
14
h-index
16
i10-index
Aditi Shah is an academic researcher from University of Southern California. The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Treatment of Major Depression. The author has an h-index of 14, co-authored 96 publications.
Papers by this author
worksPost-COVID dyspnea: prevalence, predictors, and outcomes in a longitudinal, prospective cohort
2023 · BMC Pulmonary Medicine · 32 citations
Risk of Treatment Discontinuation among Patients with Psoriasis Initiated on Ustekinumab and Other Biologics in the USA
2022 · Dermatology and Therapy · 6 citations
https://doi.org/10.1007/s13555-022-00707-z
Treatment Patterns, Acute Healthcare Resource Use, and Costs of Patients with Treatment-Resistant Depression Completing Induction Phase of Esketamine in the United States
2024 · Drugs - Real World Outcomes · 3 citations
https://doi.org/10.1007/s40801-024-00425-2
Response to the Letter to the Editor: Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA
2023 · Dermatology and Therapy · 2 citations
https://doi.org/10.1007/s13555-023-01017-8
Economic and clinical burden of major depressive disorder with insomnia symptoms in commercially and Medicaid-insured adults in the United States: A retrospective matched cohort study
2024 · Journal of Affective Disorders · 2 citations
https://doi.org/10.1016/j.jad.2024.12.048
Health Care Resource Use and Medical Costs Among Patients With Major Depressive Disorder and Acute Suicidal Ideation or Behavior Initiated on Esketamine Nasal Spray or Traditional Treatments in the United States
2025 · Clinical Therapeutics · 2 citations
https://doi.org/10.1016/j.clinthera.2024.12.006
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat